Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
Share

Pharmaceutical Outsourcing

 •  October 20

DCPrime BV and apceth Biopharma GmbH announced they have entered into a strategic manufacturing agreement. The collaboration involves clinical batch production and the development of a commercial scale manufacturing process of cancer vaccines based on DCPrime’s technology platform DCOne. The companies also announce that apceth has recently...

Pharmaceutical Outsourcing

 •  October 20

Servier CDMO announced the company has invested $7.5 million USD in intensified technology including continuous chromatography with simulated moving bed (SMB) and super critical fluid chromatography (SFC) with solvent recycling of up to 90% to lower environmental impact. Servier CDMO expects at least a 50% increase in productivity in addition to...

Pharmaceutical Outsourcing

 •  October 19

Vetter announced a major expansion of its secondary packaging capacities as a response to rising customer needs and market demands for complex packaging solutions. The need for expansion is also a result of Vetter’s growth in new filling lines and new lyophilizers, which is driving the need for increased downstream secondary packaging capacity. The...

Pharmaceutical Outsourcing

 •  October 19

Vector Laboratories announced the availability of a new guide for the growing field of immunofluorescence (IF). This new 32-page resource covers all aspects of IF and its implementation, including history of the technique’s development, the IF workflow and tips on choosing the right reagents for the application. In this new guide, Vector...

Pharmaceutical Outsourcing

 •  October 18

Pfizer CentreOne announced that it is now offering services in Nagoya, Japan. The Nagoya site will provide in-country manufacture of highly potent oral solid dosage forms. It will also provide gateway services into Japan – inspection, packaging and testing – for highly potent oral solid drugs and sterile injectables made by Pfizer CentreOne outside...

Pharmaceutical Outsourcing

 •  October 18

ValSource announced the ValSource Rapid Response Team. The team is a fast action and response group for clients needing to promptly address regulatory and compliance citation matters. The team was developed and strategically staffed to quickly mobilize and respond within the short time frames required for regulatory matters. The team is comprised...

Pharmaceutical Outsourcing

 •  October 16

CordenPharma announces a strategic investment of €3.7 million in the manufacturing site infrastructure of its CordenPharma Switzerland facility, located in Liestal, Switzerland. The investment will include an expansion of the square footage dedicated to Small Molecule, Peptide and Carbohydrate development services. In addition, significant...

Pharmaceutical Outsourcing

 •  October 16

AMRI will now offer its impurity solutions as a stand-alone service. Several trends in analytical testing are being attributed to new regulatory requirements for all new drug products, including the finalization of ICH M7 earlier this year and the upcoming required compliance of USP <232> and USP <233> by January 1, 2018. ICH M provides a practical...

Pharmaceutical Outsourcing

 •  October 13

Avara has provided an update on Hurricane Maria's impact on the company's people and manufacturing facilities at our Arecibo, Puerto Rico site. The safety and well-being of the more than 200 Avara colleagues and their families on the island remains a top priority for Avara. The company continues to provide assistance and support to the Avara staff...

Pharmaceutical Outsourcing

 •  October 12

Avantor recently opened a new life sciences research and applications laboratory in the GwangGyo district, Suwon, South Korea. The Avantor Korea Laboratory will help biopharmaceutical and pharmaceutical customers improve the efficiency of their purification processes, with an initial focus on helping them optimize Avantor’s high-performance resins,...